Skip to main content
Watch Insiders
BOLD filings

Corporate insider profile

Kevin Tang Filing Activity

Latest reported as 10% Owner of Boundless Bio, Inc. (BOLD).

Purchase filings
9
Reported companies
3
Net open-market value
$15,456,065
Latest transaction
Jul 21, 2026

Affiliated corporations

Reported company relationships

BOLDLatest reported

Boundless Bio, Inc.

10% Owner

FULCPrior filing

Fulcrum Therapeutics, Inc.

10% Owner

AUPHPrior filing

Aurinia Pharmaceuticals Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 21, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase4,863$2.44$11,866
Jul 17, 2026Fulcrum Therapeutics, Inc. (FULC)10% OwnerOpen Market Purchase167,616$3.55$594,668
Jul 16, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase63,969$2.43$155,643
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium